About 21,000 results
Open links in new tab
  1. Nexletol: Uses, Dosage, Side Effects, Warnings - Drugs.com

    Aug 5, 2024 · Nexletol (bempedoic acid) is an oral tablet for high cholesterol that may be used to lower the risk of heart attack and heart procedures (for example stent placement or bypass …

  2. In the cardiovascular outcomes trial [see Clinical Studies (14.1)], 16.4% of NEXLETOL-treated patients experienced clinically significant hyperuricemia reported as an adverse reaction …

  3. Bempedoic Acid and Cardiovascular Outcomes in Statin …

    Mar 4, 2023 · The patients were required to provide written confirmation that they were statin intolerant and aware of the benefits of statins in reducing the risk of cardiovascular events, …

  4. Nonstatin Cholesterol Medications - NEXLIZET® & NEXLETOL®

    NEXLIZET® & NEXLETOL®, nonstatin cholesterol medications, approved to lower bad cholesterol & reduce the risk of heart attack, stent placement & bypass

  5. Esperion's Bempedoic Acid Recognized by ACC as Effective LDL-C …

    Dec 19, 2025 · The bempedoic acid component of NEXLIZET and NEXLETOL is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, myocardial …

  6. NEXLIZET® & NEXLETOL® HCP Information - Official Site

    The most common adverse reactions in the cardiovascular outcomes trial for bempedoic acid, a component of NEXLIZET and NEXLETOL, at an incidence of ≥2% and 0.5% greater than …

  7. U.S. FDA Approves Broad New Labels for NEXLETOL® and

    Mar 22, 2024 · The U.S. approvals of NEXLIZET and NEXLETOL for cardiovascular risk reduction and LDL-C lowering were based on data generated from the CLEAR Outcomes trial, which …

  8. Nexletol Overview: Side Effects, Uses, Dosage, and More

    Apr 30, 2025 · Nexletol (bempedoic acid) is a prescription tablet that treats high cholesterol and reduces heart-related risks in certain adults. Learn about dosage, side effects, and more.

  9. U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® …

    Mar 22, 2024 · U.S. FDA approves broad new labels for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets to prevent heart attacks and …

  10. Efficacy of Bempedoic Acid, Novel Treatment for Elevated LDL ...

    Feb 17, 2025 · By Anthony Rice Bempedoic acid is a novel non-statin drug produced by Esperion Therapeutics to treat hypercholesterolemia, elevated levels of low-density lipoprotein (LDL) …